Role of genetic structure of Helicobacter Pylori in formation of chronic inflammatory process in gastric mucosa

Cover Page

Cite item

Full Text

Abstract

The literature review highlights the questions of the interaction of Helicobacter pylori and the human body. Modern data on the structure of the pathogenicity island in the Helicobacter pylori genome are presented. There is given a detailed description of both well-known virulence and pathogenicity factors of the infection (genes encoding the formation of urease subunits, in particular urel, cytotoxin associated gene A, vacuolating cytotoxin gen A, blood group associated binding adhesion, induced by contact with epithelium) and less studied ones (sialic acid-binding adhesion, adhesion-associated lipoprotein A and B, adhesin gene of Helicobacter pylori, Hp outer membrane protein). The significance of individual genes and proteins encoded by them in the development of chronic inflammatory process in diseases of the upper digestive tract, as well as in ulcer – and carcinogenesis is analyzed. Mechanisms of interaction of bacteria with epithelial cells of the gastric mucosa, adhesive and cytotoxic effects of Helicobacter pylori, factors of biofilm formation are described. The influence of the genetic structure of Infect on cytological composition of the gastric glands in the form of reduction of specialized glandular cells – chief and parietal cells of pyloric glands and the increase of endocrine cells in the pool is assessed. It is shown that colonization of the gastric mucosa by highly pathogenic strains of Helicobacter pylori contributes to the development of widespread pronounced and active inflammation in it, the appearance of morphological signs of atrophy. The role of the genetic characteristics of the infection in the failure of anti-helicobacter therapy is emphasized. Separately, the question of the effect of combined infection of the gastric mucosa with highly pathogenic strains of Helicobacter pylori and Epstein-Barr virus is highlighted.

About the authors

O. M. Manyakina

Medical Center «Health»

Email: an.shitova77@yandex.ru

Head of Gastroenterological Unit

Russian Federation, Yaroslavl

I. S. Akkuratova-Maksimova

Medical Center «Health»

Email: an.shitova77@yandex.ru

Candidate of Medical Sciences, doctor of Gastroenterological Unit

Russian Federation, Yaroslavl

T. G. Pukhova

Yaroslavl State Medical University

Email: an.shitova77@yandex.ru

Candidate of Medical Sciences, Associate Professor, Department of Pediatrics № 2

Russian Federation, Yaroslavl

A. S. Shitova

Yaroslavl State Medical University

Author for correspondence.
Email: an.shitova77@yandex.ru

Assistant, Department of Pediatrics № 2

Russian Federation, Yaroslavl

References

  1. Nizhevich A.A., Valeeva D.S. Helicobacter pylori infection in childhood: modern aspects of diagnosis and treatment. Bolezni zheludka i dvenadcatiperstnoj kishki u detej. Moscow: Medpraktika-M 2017; 129–201 (in Russian).
  2. Crowe S. E. Helicobacter pylori infection. New England Journal of Medicine 2019; 380: 1158–1165.
  3. Sepponen P., Maaroos H.I. Chronic gastritis. Scandinavian Journal of Gastroenterology 2015; 6 (50): 657–667.
  4. Cimmerman Ja.S. Critical analysis of the concept of the leading role of Helicobacter pylori infection in the development of gastroduodenal diseases. Klinicheskaja farmakologija i terapija 2019; 2 (19): 19–27 (in Russian).
  5. Blaser M.J. Ecology of Helicobacter pylori in the human stomach. Journal of Clinical Investigation 1997; 100 (4): 759–762.
  6. Baryshnikova N.V., Suvorov A.N., Tkachenko E.I., Uspenskij Ju.P. The role of genetic features of Helicobacter pylori in the pathogenesis of diseases of the digestive system: from theory to practice. Jeksperimental'naja i klinicheskaja gastrojenterologija 2009; 1: 52–59 (in Russian).
  7. Correa P. Does Helicobacter pylori cause gastric cancer via oxidative stress? Journal of Biological Chemistry 2006; 4 (387): 361–364.
  8. Choi Il.J., Kim C.G., Lee J.Y., Kim Y-Il, Kook M-Ch., Park B., Joo J. Family history of gastric cancer and Helicobacter pylori treatment. New England Journal of Medicine 2020; 382: 427–436.
  9. Toracchio S., Caruso R.A., Perconti S., Rigoli L, Betri E., Neri M., Verginelli F., Mariani-Costantini R. Evolutionarily-related Helicobacter pylori genotypes and gastric intraepithelial neoplasia in a high-risk area of Northern Italy. Microorganisms 2020; 3 (8): 324–330.
  10. Isaeva G.Sh., Valieva R.I. Biological properties and virulence of Helicobacter pylori. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija 2018; 1 (20): 14–23 (in Russian).
  11. Pozdeev O.K., Pozdeeva A.O., Valeeva Ju.V., Guljaev P.E. Mechanisms of interaction of Helicobacter pylori with the epithelium of the gastric mucosa. Factors contributing to successful colonization. Infekcija i immunitet 2018; 3 (8): 273–283 (in Russian).
  12. Crowe S. E. Helicobacter pylori infection. New England Journal of Medicine 2019; 380: 1158–1165.
  13. Šterbenc A., Jarc E., Poljak M., Homan M. Helicobacter pylori virulence genes. World Journal of Gastroenterology 2019; 25 (7): 4870–4884.
  14. Boonyanugomol W., Kongkasame W., Palittapongarnpim P., Baik S-C., Jung M-H., Shin M-R., Kang H-L., Lee W-K. Genetic variation in the cag pathogenicity island of Helicobacter pylori strains detected from gastroduodenal patients in Thailand. Brazilian Journal of Microbiol 2020; 51: 1093–1101.
  15. Spivak E.M., Levit R.M., Akkuratova I.S., Nadezhin A.S. Chronic gastroduodenitis in children: clinical options, features of diagnosis and treatment. Jaroslavl': Filigran' 2016; 172 (in Rus-sian).
  16. Ansari S., Yamaoka Y. Helicobacter pylori virulence factor cytotoxin-associated gene A (CagA)-mediated gastric pathogenicity. International Journal of Molecular Sciences 2020; 21: 7430–7446.
  17. Knorr J., Ricci V., Hatakeyama M., Backert S. Classification of Helicobacter pylori virulence factors: is CagA a Toxin or not? Trends in Microbiology 2019; 27: 731–738.
  18. Cover T. L. Role of Helicobacter pylori CagA in modulation gastrin expression. Gut 2012; 7 (61): 965–966.
  19. Hatakeyama M. Structure and function of Helicobacter pylori cag, the first-identified bacterial protein involved in human cancer. Proceeding of the Japan Academy Series B: Physical and Biological Science 2017; 4 (93): 196–219.
  20. Abu-Taleb A.M.F., Randa S.A., Abdel-Hady A., Omran F.H., El-korashi L.A., El-hady H.A., El-Gebaly A.M. Prevalence of Helicobacter pylori cagA and iceA genes and their association with gastrointestinal diseases. International Journal of Microbiology 2018; 4: 1–7.
  21. Sinnett C.G., Letley D.P., Narayanan G.L., Patel S.R., Hussein N.R., Zaitoun A.M., Robinson K., Atherton J.C. Helicobacter pylori vacA transcription is genetically-determined and stratifies the level of human gastric inflammation and atrophy. International Journal of Clinical Pathology 2016; 69: 968–973.
  22. Bartpho T.S., Wattanawongdon W., Tongtawee T., Paoin C., Kangwantas K., Dechsukhum C. Precancerous gastric lesions with Helicobacter pylori vacA+/babA+/oipA+ genotype increase risk of gastric cancer. BioMed Research International 2020; 18: 4–12.
  23. Kpoghomou M.A., Wang J., Wang T., Jin G. Association of Helicobacter pylori babA2 gene and gastric cancer risk: a metaanalysis. BMC Cancer 2020; 20 (1): 465–472.
  24. Gutierrez-Escobar A.J., Mendez-Callejas G., Acevedo O., Bravo M.M. Rapid evolution of the Helicobacter pylori AlpA adhesion in a high gastric cancer risk region from Colombia. Peer Journal 2018; 6 (25): 4846–4866.
  25. Horridge D.N., Begley A.A., Kim J., Aravindan N., Fan K., Forsyth M.H. Outer inflammatory protein a (OipA) of Helicobacter pylori is regulated host cell contact and mediates CagA translocation and interleukin-8 response only in the presence of a functional cag pathogenicity island type IV secretion system. Pathogens and Disease 2017; 8 (75): 31.
  26. Fauzia K.A., Miftahussurur M., Syam A.F., Waskito L.A., Doohan D., Rezkitha Y.A.A., Matsumoto T., Tuan V.P., Akada J., Yonezawa H., Kamiya S., Yamaoka Y. Biofilm formation and antibiotic resistance phenotype of Helicobacter pylori clinical isolates. Toxins 2020; 12: 473–487.
  27. Rizzato C., Torres J., Kasamatsu E., Ponce M.C., Bravo M.M., Canzian F., Kato I. Potential role of biofilm formation in the development of digestive tract cancer with special reference to Helicobacter pylori infection. Frontiers in Microbiology 2019; 10: 846–461.
  28. Kormshhikov I.S., Spivak E.M., Levit R.M. Features of chronic inflammatory process in the gastric mucosa depending on the molecular genetic characteristics of Helicobacter pylori in adolescents. Permskij medicinskij zhurnal 2014; 5 (31): 30–33 (in Rus-sian).
  29. Volynec N.V., Havkin A.I., Nikonov E.L., Murashkin V.Ju. Features of morphological changes in the gastric mucosa in children depending on Helicobacter pylori infection and Epstein – Barr virus infection. Voprosy detskoj dietologii 2018; 4 (16): 5–12 (in Rus-sian).
  30. Levit R.M., Spivak E.M., Akkuratova I.S. Features of the course of chronic gastroduodenitis associated with Helicobacter pylori in the persistence of Epstein-Barr virus in children. Voprosy detskoj dietologii 2013; 1 (11): 63–65 (in Russian).
  31. Spivak E.M., Levit R.M., Kormshhikov I.S. Features of the inflammatory process in the gastric mucosa with its combined bacterialviral infection in childhood and adolescence. Vestnik Kostromskogo gosudarstvennogo universiteta im. A.N. Nekrasova 2014; 7 (20): 56–58 (in Russian).
  32. Akkuratova I.S., Spivak E.M., Manjakina O.M. Infection of the gastric mucosa with Helicobacter pylori and Epstein-Barr virus as a factor of ineffectiveness of anti-helicobacter therapy for chronic gastritis in adolescents. Permskij medicinskij zhurnal 2019; 1 (36): 27–30 (in Russian).
  33. Levit R.M., Spivak E.M., Akkuratova I.S. Functional characteristics of cells of the gastric mucosa in its chronic inflammation in children. Vestnik Kostromskogo gosudarstvennogo universiteta im. N.A. Nekrasova 2014; 5 (14): 36–38 (in Russian).
  34. Levit R.M., Spivak E.M., Akkuratova I.S. Modern ideas about atrophy of the gastric mucosa in children and adolescents. Voprosy detskoj dietologii 2015; 3 (13): 14–16 (in Russian).
  35. Spivak E.M., Levit R.M. Modern ideas about atrophy of the gastric mucosa in children and adolescents. Voprosy detskoj dietologii 2015; 4 (13): 38–45 (in Russian).
  36. Manjakina O.M., Spivak E.M., Akkuratova I.S. Efficiency of antihelicobacter therapy in chronic gastritis in adolescents depending on the genetic structure of Helicobacter pylori. Vestnik Smolenskoj gosudarstvennoj medicinskoj akademii 2019; 1 (18): 133–136 (in Russian).
  37. Spivak E.M., Levit R.M. Modern ideas about autoimmune gastritis in childhood. Voprosy detskoj dietologii 2017; 1 (15): 25–29 (in Russian).

Copyright (c) 2021 Manyakina O.M., Akkuratova-Maksimova I.S., Pukhova T.G., Shitova A.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies